Launch week offerEnds in00h00m00s

annual Promonthly Pro

Neda Nikbakht

Associate Professor

Emory University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

About

Dr. Neda Nikbakht is an Associate Professor at Thomas Jefferson University in the United States. Her research focuses on the complexities of skin-related malignancies and their management, specifically addressing the risks of postoperative complications and the development of keratinocyte malignancies in patients with various skin conditions. Recent articles highlight her contributions to understanding T-cell lymphoma and mycosis fungoides, as well as evaluating therapeutic approaches in clinical settings.

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (21)

Raphaël Carapito

University of Strasbourg

FRANCE

Neda Nikbakht

Research Interests

Make your next move.

Explore related searches

About

Articles (20)

Human LFA-1 governs T cell immune surveillance of the skin

Spatial transcriptomics uncovers unique tumor microenvironments in folliculotropic versus classic mycosis fungoides

A CD206 targeting peptide exhibits preclinical therapeutic efficacy in cutaneous T-cell lymphoma

Increased Risk of Postoperative Complications in Hypertensive Patients Undergoing Mohs Micrographic Surgery

The Risk of Developing Keratinocyte Malignancies in Patients with Cutaneous T-Cell Lymphoma

Identifying Subsets of Cancer Patients with an Increased Risk of Developing Cutaneous Melanoma: A Surveillance, Epidemiology, and End Results–Based Analysis

CD5 Expression in CTCL and Its Implications for Anti-CD5 CAR T-Cell Therapy

The overlap of skin and blood T-cell clones in early-stage mycosis fungoides

Reduced Skin T-Cell Receptor Diversity in Large Cell Transformed Mycosis Fungoides

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.

Pleomorphic dermal sarcoma of the scalp: Review of management and distinguishing features from atypical fibroxanthoma.

Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.

Application of the current diagnostic algorithm for early mycosis fungoides to a single center cohort: Identification of challenges and suggestions for modification.

A case series of primary cutaneous B-cell lymphomas with atypical presentations: diagnostic and therapeutic challenges.

Dermal fibroblasts promote cancer cell proliferation and exhibit fibronectin overexpression in early mycosis fungoides.

Omaveloxolone attenuates squamous cell carcinoma growth and disease severity in an Epidermolysis Bullosa mouse model.

Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.

Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor

Secondary syphilis mimicking marginal zone B-cell lymphoma.

Frequent internuclear bridging in a Fanconi anemia patient with FANCG mutation.

Collaborators (21)

Raphaël Carapito

Anjali Mishra

Ramkrishna Mitra

Anne Molitor

Shen-Ying Zhang

Jean-Luc Prétet

Ahmad Yatim

Pierluigi Porcu

Vivien Béziat

Peng Zhang

Yi-Hao Chan

Stephanie Boisson-Dupuis

Roosheel Patel

Zachary Wolner

Aurélie Cobat

Mana Momenilandi

Bertrand Boisson

Mirjana Radosavljevic

Hassan Vahidnezhad

Pyung hun Park

Seiamak Bahram

Make your next move.